Who is sponsoring NCT05935956?

NCT05935956 is sponsored by NeuraLace Medical, Inc..

What drugs are being tested in NCT05935956?

Interventions in NCT05935956: Magnetic Peripheral Nerve Stimulation.

What condition does NCT05935956 study?

NCT05935956 studies Neuralgia, Neuropathic Pain, Chemotherapy-induced Peripheral Neuropathy.

Is NCT05935956 still recruiting?

NCT05935956 is currently completed. Last updated 11 July 2024.

Last reviewed 2024-07-11 · How we verify

NCT05935956: mPNS-CH

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Safety and Effectiveness of Magnetic Peripheral Nerve Stimulation for the Treatment of Chemotherapy Induced Neuropathy

Completed Last updated 11 July 2024

What this trial tests

trial testing Magnetic Peripheral Nerve Stimulation in Neuralgia in 14 participants. Completed in 21 December 2023.

Timeline

9 June 2023

Primary endpoint
21 December 2023

21 December 2023

Quick facts

Lead sponsor	NeuraLace Medical, Inc.
Status	Completed
Study type	OBSERVATIONAL
Enrollment	14
Start date	9 June 2023
Primary completion	21 December 2023
Estimated completion	21 December 2023
Sites	1 location across United States

Drugs / interventions tested

Magnetic Peripheral Nerve Stimulation

Conditions studied

Neuralgia — all drugs for Neuralgia →
Neuropathic Pain — all drugs for Neuropathic Pain →
Chemotherapy-induced Peripheral Neuropathy — all drugs for Chemotherapy-induced Peripheral Neuropathy →

Sponsor

NeuraLace Medical, Inc.

Who can join

Adults 18 to 85, any sex, with Neuralgia or Neuropathic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Assess the safety and effectiveness of Axon Therapy in the treatment of chemotherapy-induced neuropathy

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Neuralgia

Currently open trials in the same condition.

NCT06398847 — Virtual Reality (VR) Self-Hypnosis Software · NA · recruiting
NCT06796595 — Perioperative Medical Program to Optimize Nerve Regeneration After Robot-assisted Laparoscopic Neurolyses of Pudendal an · recruiting
NCT05817786 — Treatment of Upper Limb Chronic Neuropathic Pain by Electrical Stimulation of the Brachial Plexus Nerve Roots · NA · recruiting

Other NeuraLace Medical, Inc. trials

Trials by the same sponsor.

NCT05620225 — Axon Therapy and Conventional Medical Management for Painful Diabetic Neuropathy Compared to Sham and Conventional Medic · NA · completed
NCT04795635 — Axon Therapy for Post-Traumatic Peripheral Neuropathic Pain Compared to Conventional Medical Management · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05935956 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by NeuraLace Medical, Inc.
Last refreshed: 11 July 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05935956.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing